---
source_image: "spreadsheet+chart__EFTA01446944_20260130_p001_i001.png"
source_pdf: "EFTA01446944.pdf"
method: pdf_text
words: 749
confidence: 1.00
extracted: 2026-02-13T17:15:12.355942
---

4 February 2014 
Health Care Facilities and Services 
HCA Holdings, Inc. 
Model updated:04 February 2014 
tho !Rift 'Lon 
North America 
United States 
Health Care Facilities and Services 
HCA Holdings, Inc. 
Routers: HCA.N 
fileeenberg: HCA US 
Buy 
Price (3 Feb 131 
USD 48.46 
Target Price 
USO 58.00 
52 Week range 
USD 35.21 - 51.41 
Market CaP iml 
USDm 22.292 
EUHm 16,491 
.C.ornpany Pn tan 
HCA operates the largest pnvate health cat system n the 
U 5. Through a network of acute care bstipittils, outpatient 
fealties. clinics and other patent care delivery sentrgs 
HCA's operations include 162 hospitet and 112 
~mending surgery centsnl acmes 20 states throughOut 
the US. and England 
PI kJ: 2‘.0.0100070 
OD 
50 
40 
33 
20 
10 
kW 11 ~11 
Mar 12 5p12 Mr 13 54;13 
—Hotheldrokinc — 
51/16:01.4330stimill 
Marvin Tronclt 
21 
 
20 
18
17 
 
15 
 
14  
---
.. ".."."
'" ••••—.....„,.;;
:ii• -••  
• 
•
 
10 
11 
12 
13 
14E 
ISE 
........muirminfirrdn ~tin 
win 
rarowth B Pi htithbihty 
12 
10 
8 
O 
12 
IS 
11 
+am Sri« ewes asS) 
13 
let 
15E 
~noiiN451 
Solvermy 
O8 
O6 
04 
02 
0 
_4 
! 
t3 
2 
I 
i0 
ID 
11 
12 
13 
I 4E 
ISE 
rei *testar m4S, ,~I~
, Nei sømmum.141149/ 
Dacron 1.40tric h 
.1 212150-1629 
dirren lehnth@cid corn 
Page 2 
Racal year end 31•Dac 
2010 
2011 
2012 
2013 
2014E 
2015E 
Financi.21 Surninari 
DB EPS (USO) 
276 
285 
3 74 
342 
392 
477 
Reponid EPS (USD1 
278 
4 97 
349 
337 
391 
477 
DPS 6/SDI 
000 
000 
0.03 
000 
000 
000 
EIVPSIUSD) 
-27.27 
shdandon kIntric: 
-10.05 
-21.03 
-1500 
-11.14 
-671 
Price/SSW 14 
07 
0.5 
04 
0.5 
0.6 
06 
PIE (08)44 
17.2 
95 
75 
118 
174 
102 
P/E (Repfirted1(x) 
17.2 
5.4 
80 
1l9 
12.4 
102 
P/81/ 
(IT 
mm 
net 
ren 
Mn 
nm 
FCF yield (44) 
8.7 
18.9 
182 
9.5 
8.5 
105 
Dividend y1•10 
0.0 
0.0 
00 
0.0 
0.0 
00 
EV/Saird 
1.7 
14 
13 
1.4 
14 
11 
EV/EBITDA 
8.2 
6.7 
8.4 
7.2 
7.1 
8 2 
EWESIT 
108 
89 
86 
99 
95 
82 
Elm:erne Statenlent iUSDrni 
Sales 
28.035 
29.682 
33.013 
34.182 
36.596 
39.655 
EBITDA 
5.958 
6.061 
6.531 
6,574 
7.048 
7.749 
EBIT 
4.447 
4596 
4,852 
4.821 
5.238 
5,912 
Primax profit 
7,231 
3.581 
2.994 
2,946 
3,440 
4.105 
Net income 
1.207 
7.035 
1.805 
1,556 
1.807 
2,229 
(;,::";1 F10v: i1)5[200 
Cash new horn operations 
3,085 
3,933 
4,175 
3,680 
4,088 
4,580 
Net Capes 
-1.288 
-1.398 
-1.832 
-1,910 
Free cash now 
1.797 
2,535 
2.343 
1,770 
1,888 
2,330 
Equity tamm145020/4 SOO 
0 
1,003 
0 
-500 
0 
0 
Dividends paid 
0 
0 
0 
0 
0 
0 
Nit MC/dle) in borrow's)» 
7,533 
.1889 
1,724 
-687 
-LOW 
-2.030 
Other investing/fmancing cash flows 
.4,231 
•1.9137 
-3735 
On 
-494 
-512 
Net cash flow 
99 
332 
.291 
394 
-132 
Øn 
',writing capital 
799 
-129 
4.663 
-4272 
4 
-77 
 
..._
__ 
112,iFinci,.ilut171.1126;2.d 
Cmh and car, equivalens 
411 
373 
705 
414 
808 
676 
Properly, plant & equipment 
11,352 
17834 
13,185 
13,819 
14,006 
14,270 
Goodvall 
2.693 
5.251 
5.539 
5,903 
5.903 
5,903 
Other nests 
9.398 
8.440 
8.848 
8.895 
9.252 
9.614 
Total assets 
23.852 
26.898 
28.075 
28,831 
73.989 
30,463 
Debt 
28.225 
27.062 
28.930 
28,326 
27.376 
25.376 
Otte Imbrium 
8.421 
6,860 
7,486 
5.858 
6,194 
6.460 
Total Itbktes 
34.646 
33,912 
36.410 
34.234 
33.570 
31.836 
Total sharelxilders• equity 
10,794 
7,014 
43.341 
-5.403 
4.601 
-1.373 
At as 
27,874 
28679 
28225 
27,962 
26.566 
24.700 
I Key Company 5481.0C3 
Sales growth NI 
4.7 
59 
112 
3.5 
70 
57 
DB FPS growth I%) 
131 
3.3 
31 0 
8.5 
14 6 
21 
EllyOut ratio I%I 
0.0 
00 
00 
0.0 
00 
00 
EBITDA Marge. difld 
20.9 
20 4 
198 
19.2 
19 3 
200 
EBIT Margin Pb) 
15.9 
15.5 
147 
141 
14.3 
150 
ROE (54) 
rem 
on 
nm 
ren 
ren 
lee 
Nat debtrequaY (A) 
ran 
on 
nm 
arm 
ren 
rim 
Net interest cover 01 
2.1 
2.3 
2.7 
2.6 
2.9 
34 
[DuPont A.nal.rsis 
EBIT mirrin 
159 
155 
147 
14.1 
14 3 
150 
Asset turnover fa) 
1.2 
12 
12 
1.2 
12 
13 
Financial cost ratio NI 
05 
06 
06 
06 
07 
07 
Tax and other effects (a) 
0.5 
10 
05 
0.5 
05 
05 
ROA (post tas) (141 
50 
97 
513 
55 
6.1 
74 
Financial leverage (0 
-25 
.3 1 
-3.4 
-4 9 
-75 
ROE OH 
-115 
.74 4 
.179 
-1813 
-299 
-55 5 
annual swab (%) 
.54 
411.6 
267 
494 
457 
NTAfthare Imp] la) 
-23 9 
-203 
-195 
-IGO 
-13.1 
86 
Reported EPS 
276 
497 
349 
337 
392 
477 
•nnual growth f%1 
232 
80.2 
-297 
-36 
163 
218 
Source. Company obta. astaCh. Bwk es4metes 
Deutsche Bank Securities Inc. 
CONFIDENTIAL - PURSUANT TO FED. R. CRIM. P. 6(e) 
CONFIDENTIAL 
DB-SDNY-0 101397 
SDNY_GM_00247581 
EFTA01446944
